Index
-
Market Cap
48.80M
Enterprise Value
50.99M
Income
-12.70M
Sales
37.97M
Book/sh
-0.27
Cash/sh
0.81
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
83
IPO
Jun 22, 2018
P/E
-
Forward P/E
-
PEG
-
P/S
1.29
P/B
-
P/C
6.51
P/FCF
-
EV/EBITDA
-
EV/Sales
1.34
Quick Ratio
0.97
Current Ratio
1.34
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / Yes
EPS (ttm)
-1.43
EPS next Y
-0.25
EPS next Q
-0.16
EPS this Y
28.61%
EPS next Y
78.99%
EPS next 5Y
-
EPS past 3/5Y
29.44% 28.87%
Sales past 3/5Y
55.06% 55.74%
EPS Y/Y TTM
20.47%
Sales Y/Y TTM
27.26%
EPS Q/Q
66.64%
Sales Q/Q
11.52%
Insider Own
32.89%
Insider Trans
-2.87%
Inst Own
13.28%
Inst Trans
10.44%
ROA
-65.70%
ROE
-478.70%
ROIC
-196.11%
Gross Margin
86.13%
Oper. Margin
-33.15%
Profit Margin
-33.46%
SMA20
-29.83%
SMA50
-41.75%
SMA200
-31.66%
Trades
Shs Outstand
9.17M
Shs Float
6.19M
52W High
12.70 -58.35%
52W Low
4.41 19.95%
Volatility
23.90% 13.59%
ATR (14)
1.00
RSI (14)
31.30
Beta
1.19
Rel Volume
6.61
Avg Volume
93.73K
Volume
619,706
Perf Week
-39.89%
Perf Month
-35.49%
Perf Quarter
-46.94%
Perf Half Y
-17.73%
Perf YTD
17.95%
Perf Year
-12.71%
Perf 3Y
-7.84%
Perf 5Y
-61.67%
Perf 10Y
-
Prev Close
7.71
Price
5.29
Change %
-31.39%
Analysts 4 incl. previous ratings
Rating Distribution 2 Buy · 2 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Aug 14, 2020 Upgrade B BTIG Research
Neutral → Buy $3.50 -33.8% Nov 14, 2019 Downgrade J JMP Securities
Mkt Outperform → Mkt Perform Sep 26, 2019 Resumed C Cantor Fitzgerald
Neutral $9 +70.1% May 30, 2019 Downgrade C Cantor Fitzgerald
Overweight → Neutral May 15, 2019 Downgrade B BTIG Research
Buy → Neutral May 09, 2019 Initiated N Noble Capital Markets
Outperform Sep 21, 2018 Initiated C Cantor Fitzgerald
Overweight
Today 08:00AM
Nov-05-26 08:00AM
Nov-04-26 07:03PM
(Earnings Whispers)
+16.18%
04:05PM
Oct-29-26 11:50AM
08:00AM
Loading…
08:00AM
Oct-28-26 08:00AM
Oct-27-26 08:00AM
Oct-21-26 08:00AM
Sep-10-26 08:00AM
Sep-09-26 08:00AM
Aug-25-26 08:00AM
Aug-06-26 04:05PM
Aug-03-26 08:00AM
Jul-30-26 08:00AM
08:00AM
Loading…
Jul-16-26 08:00AM
Jun-17-26 08:00AM
Jun-09-26 08:00AM
Jun-02-26 08:00AM
May-13-26 08:00AM
May-08-26 08:00PM
May-06-26 04:05PM
Apr-30-26 08:00AM
Apr-29-26 08:00AM
Apr-28-26 08:00AM
Apr-23-26 08:00AM
Apr-08-26 08:00AM
Apr-07-26 08:00AM
Apr-01-26 08:00AM
Mar-31-26 08:00AM
08:00AM
Loading…
Mar-30-26 08:00AM
Mar-26-26 03:11AM
Mar-23-26 09:01PM
Mar-19-26 04:05PM
Mar-18-26 12:15PM
Mar-10-26 08:00AM
Mar-09-26 08:00AM
Mar-05-26 10:00AM
Mar-04-26 05:55PM
10:00AM
Feb-27-26 07:15AM
Jan-21-26 08:00AM
Jan-20-26 08:00AM
Dec-02-25 08:00AM
Nov-10-25 04:05PM
Nov-05-25 06:35PM
04:05PM
Nov-04-25 08:50AM
Oct-29-25 10:00AM
Oct-23-25 08:11AM
Oct-03-25 04:05PM
Sep-30-25 08:00AM
Sep-29-25 08:00AM
Sep-22-25 08:00AM
Sep-10-25 04:05PM
Sep-05-25 08:00AM
Sep-04-25 08:00AM
Sep-03-25 08:00AM
Sep-02-25 08:00AM
Aug-12-25 08:00AM
Aug-06-25 05:35PM
04:05PM
Aug-05-25 05:55PM
10:35AM
08:00AM
Jul-23-25 08:00AM
Jul-22-25 04:05PM
Jul-14-25 10:01AM
May-09-25 11:00AM
May-07-25 11:18PM
11:16PM
06:15PM
04:05PM
01:36PM
May-05-25 04:48AM
May-02-25 08:00AM
May-01-25 08:00AM
Apr-30-25 08:00AM
Apr-17-25 08:00AM
Apr-16-25 08:00AM
Apr-03-25 08:00AM
Apr-01-25 08:00AM
Mar-31-25 08:00AM
Mar-13-25 03:11AM
Mar-12-25 05:15PM
04:05PM
Mar-06-25 08:00AM
Mar-05-25 08:00AM
Feb-27-25 08:00AM
Feb-19-25 08:00AM
Feb-18-25 07:59AM
Feb-06-25 08:00AM
Feb-04-25 08:00AM
Jan-07-25 08:00AM
Jan-02-25 11:09AM
Dec-17-24 04:05PM
04:05PM
Nov-20-24 08:00AM
Nov-19-24 08:00AM
Nov-14-24 08:00AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Errico Thomas J. Director Sep 14 '26 Buy 9.82 5,000 49,082 363,904 Sep 22 07:00 AM Lev Joshua S. CFO and Interim President Aug 21 '26 Option Exercise 4.50 12,000 54,000 96,889 Aug 25 05:30 PM Lev Joshua S. CFO and Interim President Aug 24 '26 Option Exercise 4.50 5,000 22,500 89,889 Aug 25 05:30 PM Lev Joshua S. CFO and Interim President Aug 25 '26 Option Exercise 4.50 3,000 13,500 87,889 Aug 25 05:30 PM Lev Joshua S. CFO and Interim President Aug 21 '26 Sale 10.22 12,000 122,640 84,889 Aug 25 05:30 PM Lev Joshua S. CFO and Interim President Aug 24 '26 Sale 9.88 5,000 49,400 84,889 Aug 25 05:30 PM Lev Joshua S. CFO and Interim President Aug 25 '26 Sale 9.36 3,000 28,080 84,889 Aug 25 05:30 PM Errico Thomas J. Director Aug 13 '26 Buy 9.85 5,000 49,272 343,332 Aug 17 06:19 AM Goldberger Daniel S Former Officer & Director Apr 23 '26 Sale 6.80 80,000 544,000 211,471 Jun 12 06:12 PM Lev Joshua S. CFO and Interim President May 28 '26 Sale 9.00 6,667 60,003 84,889 May 29 04:05 PM Joshua S. Lev Interim President and Chief Fi May 27 '26 Proposed Sale 8.91 6,667 59,403 May 27 08:40 PM PATTON THOMAS M Director May 22 '26 Proposed Sale 7.24 85,000 615,658 May 27 01:17 PM Errico Thomas J. Director May 21 '26 Buy 5.99 9,992 59,852 360,071 May 26 08:52 AM Lev Joshua S. CFO and Interim President May 22 '26 Sale 6.50 3,000 19,500 91,556 May 22 06:11 PM Goldberger Daniel S Former Affiliate May 14 '26 Proposed Sale 6.48 45,000 291,600 May 14 03:48 PM Goldberger Daniel S Former Affiliate May 05 '26 Proposed Sale 6.72 25,000 168,000 May 05 10:37 AM Goldberger Daniel S Former CEO Apr 23 '26 Proposed Sale 6.13 10,000 61,300 Apr 23 12:43 PM Goldberger Daniel S Former Officer and Director Apr 10 '26 Sale 6.02 16,072 96,753 291,471 Apr 14 04:05 PM Lev Joshua S. Chief Financial Officer Dec 04 '25 Sale 5.05 2,500 12,625 21,667 Dec 05 04:15 PM Goldberger Daniel S Chief Executive Officer Dec 02 '25 Buy 4.84 1,000 4,840 292,565 Dec 03 07:00 AM
electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Rockaway, NJ.
Founder & Independent Chairman Dr. Thomas J. Errico M.D.
CFO Mr. Joshua S. Lev
COO Mr. Michael Fox
Vice President of HR & Employee Success Ms. Jennifer A. Hayes
M.D. Dr. Peter S. Staats M.B.A.